Latest News from: La Jolla Institute for Immunology

Filters close
Released: 19-Nov-2024 12:25 PM EST
La Jolla Institute for Immunology Launches New International Research Partnership with Link Campus University
La Jolla Institute for Immunology

La Jolla Institute for Immunology (LJI) and Link Campus University of Rome, Italy, and have signed a collaborative agreement as part of a strategic program aimed at promoting scientific research and innovation between the United States and Italy.

Newswise: Expert Alert: San Diego Scientist Available to Comment on Local Dengue Case
Released: 10-Oct-2024 11:05 AM EDT
Expert Alert: San Diego Scientist Available to Comment on Local Dengue Case
La Jolla Institute for Immunology

LA JOLLA, CA—La Jolla Institute for Immunology (LJI) Professor Sujan Shresta, Ph.D., is on hand to share her expertise on dengue fever and dengue vaccine development. She is available to comment on urgent dengue virus research amidst the news of San Diego’s first locally acquired dengue virus case. LJI Professor Sujan Shresta, Ph.

Newswise: LJI Discovery Paves the Way for Antivirals Against Ebola Virus and Its Deadly Relatives
Released: 17-Sep-2024 5:05 PM EDT
LJI Discovery Paves the Way for Antivirals Against Ebola Virus and Its Deadly Relatives
La Jolla Institute for Immunology

The new study, led by researchers in the Saphire Lab at LJI, reveals the inner workings of the Ebola virus nucleocapsid. LA JOLLA, CA—At this moment, the world has few tools to combat deadly filoviruses, such as Ebola and Marburg viruses. The only approved vaccine and antibody treatments protect against just one filovirus species.

Released: 16-Sep-2024 1:05 PM EDT
T cells may offer some protection in an H5N1 'spillover' scenario
La Jolla Institute for Immunology

The LJI team uncovered important similarities between H5N1 and these common viruses, which allowed them to predict that many people already have "cross-reactive" T cells that are ready to target H5N1—should it ever mutate to cause widespread disease in humans.

Released: 11-Sep-2024 12:05 PM EDT
LJI Selected as Member of ARPA-H Investor Catalyst Hub Spoke Network
La Jolla Institute for Immunology

La Jolla Institute for Immunology (LJI) has been selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H).

Released: 22-Aug-2024 1:05 PM EDT
LJI scientists lead new mpox research
La Jolla Institute for Immunology

Scientists at La Jolla Institute for Immunology (LJI) are investigating how the mutated clade 1 mpox virus may affect children and older patients—and how new vaccines can help the body fight back.

Newswise: Sydney Ramirez receives prestigious Burroughs Wellcome Fund Career Award
Released: 20-Jun-2024 10:05 AM EDT
Sydney Ramirez receives prestigious Burroughs Wellcome Fund Career Award
La Jolla Institute for Immunology

"As an infectious diseases clinician, I've always been focused on research into pathogen-host interactions. We need to know why some people get sicker than others."

18-Jun-2024 12:00 PM EDT
New research points to 'stem-like' T cells as culprits in ulcerative colitis
La Jolla Institute for Immunology

The researchers hope to one day target this T cell population via drug therapy. "These cells may be a very important target for treating ulcerative colitis and perhaps other autoimmune diseases..."

Newswise: LJI scientists develop new method to match genes to their molecular ‘switches’
Released: 3-Jun-2024 1:05 PM EDT
LJI scientists develop new method to match genes to their molecular ‘switches’
La Jolla Institute for Immunology

LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have developed a new computational method for linking molecular marks on our DNA to gene activity. Their work may help researchers connect genes to the molecular “switches” that turn them on or off. This research, published in Genome Biology, is an important step toward harnessing machine learning approaches to better understand links between gene expression and disease development.

Newswise: How COVID-19 'breakthrough' infections alter your immune cells
Released: 24-May-2024 12:05 PM EDT
How COVID-19 'breakthrough' infections alter your immune cells
La Jolla Institute for Immunology

Repeated vaccination and infection leads T cells and B cells to build an "immunity wall"

Newswise: LJI scientist Alison Tarke honored by Italian government
Released: 7-May-2024 12:05 PM EDT
LJI scientist Alison Tarke honored by Italian government
La Jolla Institute for Immunology

“Alison’s research has been very, very impactful, and her efforts have catalyzed a cultural exchange between the United State and Italy."

Newswise: Researchers reveal how protein modifications power T cells
Released: 29-Apr-2024 1:05 PM EDT
Researchers reveal how protein modifications power T cells
La Jolla Institute for Immunology

This method is a major leap forward for scientists investigating how proteins do their jobs in the immune system. “This method basically creates an entire new kind of world of experiments that people can do..."

Newswise: LJI home to new
Released: 17-Apr-2024 12:05 PM EDT
LJI home to new "Center of Excellence"
La Jolla Institute for Immunology

The Institute's Flow Cytometry Core, which provides cutting-edge research services, has been named a BD Biosciences "Center of Excellence." Along with this distinction, the LJI Flow Core has brought in a sophisticated instrument for immune cell research: the BD FACSDiscover™ S8 Cell Sorter.

Newswise: Vac to the future
Released: 14-Mar-2024 3:05 PM EDT
Vac to the future
La Jolla Institute for Immunology

“We are hoping to use this competition not just as a way to examine the capacity of people to predict vaccination outcomes, but also as a way to address an important public health question,” says Peters.

Newswise: LJI welcomes new faculty member Miguel Reina-Campos, Ph.D.
Released: 1-Mar-2024 12:05 AM EST
LJI welcomes new faculty member Miguel Reina-Campos, Ph.D.
La Jolla Institute for Immunology

Cancer researcher Miguel Reina-Campos, Ph.D., has joined the faculty of La Jolla Institute for Immunology (LJI) as an Assistant Professor to lead the Laboratory of Tissue Immune Networks. His laboratory at LJI aims to investigate the basis of CD8+ T cell tissue immunity to improve life-saving cancer immunotherapies.

Newswise: How T cells combat tuberculosis
Released: 6-Feb-2024 11:05 AM EST
How T cells combat tuberculosis
La Jolla Institute for Immunology

Scientists at La Jolla Institute for Immunology (LJI) have uncovered important clues to how human T cells combat the bacterium that causes tuberculosis.

Newswise:Video Embedded how-late-rising-t-cells-combat-a-stubborn-virus
VIDEO
Released: 18-Jan-2024 3:05 PM EST
How 'late-rising' T cells combat a stubborn virus
La Jolla Institute for Immunology

“We found sort of a special ‘flavor’ of CD4+ T cells critical for clearing this chronic virus replication,”

Released: 18-Jan-2024 2:05 PM EST
Researchers discover potentially cancer-fighting T cells within some pediatric brain tumor patients
La Jolla Institute for Immunology

"These patients may be candidates in whom immunotherapy has the potential to show clinical benefit."



close
0.32092